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ABSTRACT
This study analyzed the predictive power of sociodemographic 
(age, sex) and medical variables (months since diagnosis and in 
treatment, immunotherapy, number of environmental allergens, 
food allergies or atopic dermatitistypes) on the quality of life of 
patients with rhinoconjunctivitis and bronchial asthma, using mod-
els based on comparative qualitative fuzzy analysis to compare 
them according to the pathology(s).
Retrospective cross-sectional design.Sixty-four adolescents 
(65.60% boys) diagnosed with rhinoconjunctivitis and/or bronchial 
asthma aged between 12 and 16 years old (M= 14.02; SD = 1.45).
The data were collected between February 2019 and 
January 2020 using the Brief Disease Perception Questionnaire 
(B-IPQ), the Adolescent Rhinoconjunctivitis Quality of Life 
Questionnaire (AdolRQoLQ) and the Respiratory Disease 
Questionnaire Self-administered and Standardized Chronicle (CRQ- 
SAS). Qualitative comparative analysis models (QCA) were used.
In the QCA models, the various combinations indicated that the 
variables that predicted a higher quality of life for both rhinocojun-
tivitis symptoms and respiratory symptoms were receiving longer- 
term immunotherapy and a perceived lower threat of the disease. 
The consistencies of the models vary between 23–29%. In conclu-
sion, the patients’ QoL was explained by the presence of longer- 
term immunotherapy and a less threatening perception of the 
disease.
Therefore, early multidisciplinary diagnosis and treatment is 
important.
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Allergic diseases are among the most common chronic diseases during childhood and 
adolescence, and have increased considerably in recent years (Cibella et al., 2015). The 
prevalence of allergic diseases varies depending on the diagnostic criteria considered, the 
age of the samples studied and the place of origin (Rodríguez Rodríguez et al., 2017). 
Around 7–20% of children and adolescents suffer from allergic diseases, with the 
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presence of allergic rhinoconjunctivitis (ARC) and atopic dermatitis being very frequent, 
and to a lesser extent, allergic asthma and food allergy (Ojeda et al., 2018; Tang & 
Mullins, 2017; Trisan-Alonso et al., 2014). The prevalence of asthma was 2% in 
Indonesia, it was 32% in the United Kingdom and between 5.50% – 15.40% in Spain 
(Rodríguez Rodríguez et al., 2017). There is considerable variability in the prevalence and 
incidence of the disease between different ethnicities. Although the causes of these 
differences are unclear, they may be due to the influence of genetic and environmental 
factors, and differences in the diagnosis, treatment, and prevention of the disease 
(Umławska et al., 2013).
There is a high degree of comorbidity between different allergic diseases, and as such 
ARC is considered a risk factor for the development of asthma (Stern et al., 2019). Indeed, 
ARC and asthma can be considered manifestations of the same disease in two parts of the 
respiratory tract (Togias et al., 2019). In addition, 25% of adolescents with asthma have 
food allergy, and most of them also have atopic dermatitis (Gore et al., 2016; Stern et al., 
2019).
The therapeutic strategy for allergic diseases includes patient education, avoidance of 
allergens and contaminants, allergen-specific pharmacotherapy and immunotherapy 
(Lang & Portnoy, 2017; Ray et al., 2016). Many pediatric patients receive immunotherapy 
(Frew, 2010), since although it generally consists of a monthly injection for 3 to 5 years, 
the effects persist and include the prevention of new allergies (Wise et al., 2018). 
Although the medication received varies greatly depending on the number of allergens, 
the type of expression of the allergy and its severity (GEMA, 2018), the barriers to 
compliance are similar. The main barriers are the unadjusted perception of the disease, 
as well as the perception of peers and family about the disease (De Benedictis & Bush, 
2017).
Suffering from an allergy has a significant impact on adolescents’ quality of life (QoL), 
rest, activities of daily living and even academic performance (Blaiss et al., 2018; Devillier 
et al., 2016; Robinson et al., 2017). The concomitant presence of asthma implies poorer 
control and response to medical treatment for adolescents with ARC, which is accom-
panied by a greater severity and duration of the disease, and therefore a greater impact on 
the QoL (Mariño-Sánchez et al., 2018),
The adolescents’ beliefs about the disease, its degree of control, severity and chroni-
city, are associated with the psychological health of patients with allergic diseases 
(Fellows et al., 2020), and these can influence their QoL (Colombo et al., 2019; James 
& Caballero, 2020) and their emotional well-being (Confino-Cohen et al., 1999). 
Adolescents with allergic pathologies perceive their diseases as being not very under-
standable but long-lasting, and conclude that the potential threat to their health is 
moderate (Colombo et al., 2019; James & Caballero, 2020), despite having successfully 
completed immunotherapy treatment (Confino-Cohen et al., 1999). As for sociodemo-
graphic variables, the literature has highlighted how adolescent girls tend to perceive 
their disease as more threatening than adolescent boys with more symptoms, and 
therefore present a more marked deterioration of their QoL (Colombo et al., 2019; 
James & Caballero, 2020).
While various studies have analyzed the importance of each variable separately, there 
are few studies in the field of health psychology and medicine that have addressed them 
in overall terms following linear methodologies (Castellano et al., 2019; Valero-Moreno, 
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et al., 2020; Villanueva et al., 2019). On that basis, the present study uses Qualitative 
Comparative Analyses (QCA) The objective was to analyze the effect of sociodemo-
graphic variables and medical variables (presence of food allergy or atopic dermatitis, 
immunotherapy treatment, immunotherapy time and number of allergens) and the 
threat of disease on the QoL of patients with ARC and asthma using QCA. The 
hypotheses were: (H1) In comparison to boys, girls with more symptoms will present 
a lower QoL; (H2) Adolescents who received immunotherapy for a longer period 
presented a better QoL in comparison to adolescents receiving immunotherapy for 
a shorter period; (H3) Threat perception is negatively related to QoL; (H4): 
Comorbidity of pathologies (atopic dermatitis, food allergy or higher number of aller-
gens) is negatively related to QoL.
Method
Procedures
This was an observational and cross-sectional study. The data was collected between 
February 2019 and January 2020, at the Valencia General Hospital Consortium. 
Adolescent patients with allergic asthma were eligible to participate if they had received 
a diagnosis of rhinitis or ARC at least 6 months previously, they were 12–16 years old, and 
regularly attended the Hospital’s Pediatric Allergology. Patients were excluded if they had any 
neurological problems, oncological disease or psychological diagnosis prior to the diagnosis.
The data was collected by members of the research team. Informed consent was 
requested from legal guardians, who were informed of the characteristics of the study, 
assured of the commitment to confidentiality, and about the recording of personal data. 
The permission of the Ethics Committees of the Valencia General Hospital Consortium 
and the reference hospital was obtained (H1435211034634).
Participants
The sample consisted of 64 Spanish adolescents (65.60% boys) aged 12–16 years 
(M= 14.02; SD = 1.45). All the adolescents had been diagnosed with asthma and rhinitis 
or rhinocojuntivitis.
Data collection
The variables analyzed were as follows:
Sociodemographic and medical variables
An ad hoc questionnaire was developed with questions concerning the following infor-
mation: age, sex, months since diagnosis and in treatment, immunotherapy received if 
any and time receiving immunotherapy, number of environmental allergens, and comor-
bidity with food allergy or atopic dermatitis.
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Psychological variables
The Brief Disease Perception Questionnaire (B-IPQ): this is a measure of patients’ 
cognitive and emotional representations of their disease (Broadbent et al., 2006; Pacheco- 
Huergo et al., 2012). This study used a new version, adapted and validated for patients 
with chronic pediatric disease by Valero-Moreno et al. (2020). The scale consists of 5 
items, which are graded from 0 to 10, in which the higher the total score, the greater the 
perception of the disease as a threat. The scale has demonstrated adequate psychometric 
properties Valero-Moreno, Castillo-Corullón et al. (2020) and has a reliability of .77 in 
this study.
The Health-related quality of life was assessed using specific questionnaires for allergic 
rhinoconjunctivis (AdolRQOLQ) and respiratory symptoms associated with bronchial 
asthma (CRQ-SAS).
The Adolescent Rhinoconjunctivitis Quality of Life Questionnaire (AdolRQOLQ): 
AdolRQOLQ is a quality of life assessment instrument for use specifically for the 
pediatric population with ARC (Juniper et al., 1994). It measures the impact, frequency 
and severity of allergic symptoms on the daily functioning of patients (De Graaf-in 
T Veld et al., 1996). It is composed of 25 direct items with 7 levels (ranging from 
0 = ‘didn’t bother me at all’ to ‘6 = bothered me a lot’). A higher score is indicative of 
a poorer QoL (Malizia et al., 2018). AdolRQOLQ has been shown to be a valid instrument 
(Juniper et al., 2007), and shows a reliability of .96 in this study.
The Respiratory Disease Questionnaire Self-administered and Standardized Chronicle 
(CRQ-SAS) (Vigil et al., 2011) adapted to the paediatric population with respiratory 
symptoms (Valero-Moreno et al., 2019). This consists of a total of 20 items grouped into 
four dimensions (dyspnea, fatigue, emotional function and disease control). The answers 
range from 1 to 7, with 1 being the most severe impact on QoL. Previous studies indicate 
adequate psychometric properties (Al Moamary & Tamim, 2011; Valero-moreno et al., 
2019; Vigil et al., 2011). It presented a reliability of .89 in our study.
Data analysis
Mean and standard deviations were calculated for the variables analyzed, and recoding 
took place according to cut-off points, and t-tests were performed to analyze the mean 
differences between groups using the SPSS statistical software package. The raw data 
from the participants’ responses had to be transformed for the QCA. QCA models are 
based on a Boolean or intersection logic and assume the influence of an attribute or 
attributes on a specific outcome (equifinality). First, as suggested in the literature 
(Ragin, 2008), all the missing data were eliminated and all the conditions (variables) 
were calculated by multiplying the scores for their items. The values had to be 
recalibrated between 0 and 1 before the analysis was performed. When considering 
only two values, we used 0 (does not have the characteristic) and 1 (has the char-
acteristic). With continuous variables or with factors from a survey, it was necessary to 
consider the following three thresholds: 10% (low-level or totally outside the set), 50% 
(intermediate level, neither inside nor outside the set), and 90% (high level or totally 
inside the set). These three values had to be entered in order to perform an automatic 
re-calibration of values between 0 and 1. In this case, the fsQCA software re-calibrated 
the values for psychological variables considering the three thresholds (Woodside, 
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2013). The analysis establishes the necessary causes, which must always be present for 
a given result to occur. In addition, the sufficient conditions, which, although they do 
not always have to be present for a result to occur, can give rise to a specific result. 
QCA models enable the identification of the percentage of variance explained, or the 
cases in which the model is fulfilled, i.e. the coverage, and the indicators of goodness 
of fit, i.e. the consistency (Eng & Woodside, 2012; Ragin, 2008). A condition is 
considered necessary when its consistency is ≥.90 (Ragin, 2008) and for sufficiency, 
a model is informative when the consistency is around or above .74 (Eng & Woodside, 




The number of years since diagnosis (M = 77.48 months; SD = 52.38 months) and 
treatment (M = 53.98 months; SD = 47.64 months) were similar. A majority of 
participants (73.3%) were currently receiving immunotherapy. The average duration 
of immunotherapy at the time of the assessment was approximately two and a half 
years (M = 32.61; SD = 27.98), ranging from 0 (never received immunotherapy or 
receiving their first dose) to 168 doses of immunotherapy. In addition to ACR and 
asthma, 20.3% presented a food allergy, and 31.3% of the total also presented atopic 
dermatitis.
Psychological variables
Quality of life (CRQ-SAS vs AdolRQRQ)
The results for QoL in allergic asthma patients were that patients generally presented an 
adequate QoL in both respiratory symptoms and rhinoconjunctivitis. The results for the 
ADOLrQoLQ were low scores, indicating a good QoL (measured as lower scores, better 
QoL). The subscales with the highest scores were for symptoms of rhinitis and practical 
problems (difficulty concentrating, doing schoolwork, difficulty sleeping, etc.) see (Figure 
1). Meanwhile, in the CRQ-SAS questionnaire (respiratory symptoms), higher scores 
indicated a better QoL. The results show high scores (Figure 2). The scales that obtained 
the lowest scores were fatigue and emotional function.
Qualitative comparative analysis of diffuse sets (QCA)
First, in accordance with the literature, necessary analyses were performed (Table 1), 
followed by sufficiency analyses (Table 2). QoL in rhinocojuntivitis and in respiratory 
symptoms were established as the criterion variables (outcome condition), and sex, 
immunotherapy, duration of immunotherapy, number of allergens, the presence of 
food allergy and atopic dermatitis and the perceived threat of disease were established 
as predictor variables (causal conditions).
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Necessity analysis
There is no necessary condition for high and low levels of QoL in rhinoconjunctivitis and 
in respiratory symptoms (Table 2), because its consistency was lower than 90.
Figure 1. Average scores from the AdolqrQRQ questionnaire and its sub-dimensions.
Figure 2. Average scores from the CRQ-SAS questionnaire and its sub-dimensions.
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Sufficiency analysis
The resulting models for each dimension provided the following results: in predicting 
high levels of QoL in rhinoconjunctivitis (measured in reverse, with higher scores 
denoting a poorer QoL), eight pathways were observed that explained 50% of the cases 
with high levels (total consistency = .96; total coverage = .50). The most relevant 
pathways for predicting high levels of QoL in rhinoconjunctivitis were the result of 
the interaction between high levels of disease threat, having a food allergy, receiving 
immunotherapy and shorter immunotherapy duration (raw coverage = .15, consis-
tency = .91) (Table 3). Meanwhile, for predicting low levels QoL in rhinoconjunctivitis, 
six pathways were observed that explained 53% of the cases with low levels (total 
consistency = .91; total coverage = .53). The most relevant combinations were the result 
of few allergens, a shorter immunotherapy duration, no immunotherapy and being 
a boy (raw coverage = .23, consistency = .93), which explained 23% of the cases with 
low levels.







Quality of life respira-
tory symptoms
Quality of life rhinoconjunc-
tivitis symptoms
M 32.10 2.72 5918.23 318 308.92 89 833.71
SD 28.05 1.80 11 482.70 165 206.85 127 355.31
Min 0 1 4 21 420 1664
Max 120 8 57 600 675 024 566 082
P10 0 1 20 106 343 3909.30
P50 24 2 813 321 048 30 450
P90 60 5 18 477 544 887 294 692.40
Note. M: mean; SD: standard deviation; Min: minimum; Max: maximum; P10: 10th percentile; P50: 50th percentile; P90: 90th percentile
Table 2. Necessary analysis for health-related quality of life (ADOLrQoLQ and CRQ-SAS).
AdolrQoLQ CRQ-SAS
High levels of 
ADOLrQoLQ (worse 
quality of life in 
rhinoconjunctivitis)
Low levels of 
ADOLrQoLQ (better 
quality of life in 
rhinoconjunctivitis)
High levels of 
quality of life 
in respiratory 
symptoms
Low levels of 
quality of life 
in respiratory 
symptoms
Cons Cov Cons Cov Cons Cov Cons Cov
Girl .41 .59 .23 .41 .24 .33 .42 .67
Boy .59 .39 .76 .61 .76 .54 .58 .46
Immunotherapy .30 .59 .17 .41 .20 .39 .28 .61
No immunotherapy .70 .41 .83 .59 .80 .50 .72 .50
Increased immunotherapy duration .59 .52 .63 .67 .72 .64 .52 .51
Shorter immunotherapy duration .62 .59 .54 .61 .46 .46 .64 .72
Many allergens .62 .57 .56 .62 .59 .55 .60 .63
Few allergens .59 .53 .61 .66 .61 .58 .57 .61
Food allergy .81 .45 .82 .55 .82 .48 .77 .52
No food allergy .19 .47 .18 .53 .18 .42 .23 .58
Atopic dermatitis .66 .42 .73 .57 .73 .50 .64 .50
No atopic dermatitis .34 .51 .27 .49 .27 .40 .36 .60
High levels of disease threat .71 .80 .39 .53 .39 .43 .67 .83
Low levels of disease threat .58 .44 .85 .78 .84 .70 .53 .50
Note: AdolrQoLQ: quality of life in rhinoconjunctivitis; CRQ-SAS: quality of life in bronchial asthma; Cons: consistency; Cov coverage; ~: absence of condition; 
condition needed: consistency ≥.90
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In predicting high levels of QoL for respiratory symptoms, six pathways were observed 
that explained 39% of the cases with high levels (total consistency = .93; total cover-
age = .39). The most relevant pathways for predicting high levels of QoL for respiratory 
symptoms were the result of the interaction between low levels of disease threat, having 
atopic dermatitis, many allergens, increased immunotherapy duration and being a boy 
(raw coverage = .20, consistency = .90). Meanwhile, for predicting low levels of QoL in 
respiratory symptoms, nine pathways were observed that explained 43% of the cases 
(total consistency = .96; total coverage = .43). The most relevant combinations were the 
result of high levels of disease threat, having atopic dermatitis, shorter immunotherapy 
duration and receiving immunotherapy (raw coverage = .12, consistency = .94), which 
explained 12% of the cases with low levels.
Discussion
Few studies focus on the QoL of adolescents with allergic diseases (Kansen et al., 2018; 
Muraro et al., 2014; Van Der Velde et al., 2011) and to the best of our knowledge, they 
have been carried out using linear methodologies. This study therefore proposed 
a methodology that provides different combinations of explanations for the same phe-
nomenon. As regards the objective of our research, to find the explanatory factors of the 
affectation of QoL in adolescents with asthma and ARC, our results show that in general 
the presence of ARC and asthma may compromise the QoL of adolescents. It seems that 
the perception of the disease in adolescents must be very threatening and they must not 
be receiving any immunotherapy (or have received it for a very short time) for it to 
Table 3. Summary of the three main conditions sufficient for the intermediate solution of Health- 
related quality of life.
AdolrQoLQ CRQ-SAS
Frequency cut-off 1
High levels of 
ADOLrQoLQ (worse 
quality of life in rhino-
conjunctivitis) 
Consistency cut-off .87
Low levels of 
ADOLrQoLQ (better 
quality of life in rhino-
conjunctivitis) 
Consistency cut-off .88
High levels of 





Low levels of 





1 2 3 1 2 3 1 2 3 1 2 3
Girl ● ○ ○ ○ ○ ○ ○
Immunotherapy ● ● ○ ○ ● ● ○
Immunotherapy duration ○ ○ ○ ● ● ● ● ○ ○ ○
Number of allergens ○ ● ● ○ ○
Food allergy ● ○ ● ● ● ○
Atopic dermatitis ● ● ● ● ○ ● ○ ●
Levels of disease threat ● ● ● ○ ● ○ ○ ● ● ●
Raw coverage .15 .10 .09 .23 .18 .12 .20 .09 .05 .12 .09 .08
Unique coverage .10 .07 .05 .13 .11 .02 .15 .06 .03 .04 .03 .02
Consistency .91 1 .95 .93 .96 .93 .90 .93 .98 .94 .99 .99
Overall solution consistency .96 .91 .93 .96
Overall solution coverage .50 .53 .39 .43
Note: AdolrQoLQ: quality of life in rhinoconjunctivitis; CRQ-SAS: quality of life in bronchial asthma; Expected vector for high levels of quality of life in 
rhinoconjunctivitis: 1,0,0,1,1,1,1 (according to Fiss nomenclature) (Fiss,  
2011)Expected vector for low levels of quality of life in rhinoconjunctivitis:0,1,1,0,0,0,0 ●=presence of condition, ○=absence of condition, ~=absence of 
condition. Expected vector for high levels of quality of life in respiratory symptomatology 0,1,1,0,0,0,0. Expected vector for low levels of quality of life in 
respiratory symptomatology: 1,0,0,1,1,1,1
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present any impact on their QoL. In our study, we found that most adolescents have 
a good QoL, which is accompanied by a low threat perception of allergic disease (James & 
Caballero, 2020) this result would confirm H3.
As a result, adolescents who present a low QoL in terms of their respiratory symptoms 
have atopic dermatitis do not receive immunotherapy, and perceive the disease as very 
threatening, simultaneously validating H2, H3 and H4. In our results, we observed that 
a high QoL in terms of respiratory symptoms generally occurs in boys with a low 
perception of the threat of the disease, partially validating H1 and H3. This condition 
persists even in cases presenting food allergy and atopic dermatitis as indicated by the 
studies, and this confirms H4 (Colombo et al., 2019; James & Caballero, 2020).
In addition, low QoL related to rhinoconjunctivitis symptoms was consistently asso-
ciated with a greater perceived threat, food allergy, and no or recent immunotherapy 
treatment, therefore supporting H2, H3 and H4. The comorbid presence of several 
allergic diseases can seriously compromise the QoL of adolescents, with reports of 
increased perceived symptoms associated with nose and eye symptoms, validating H4.
A better QoL related to the symptomatology of rhinoconjunctivitis occurred in boys 
and was associated with fewer allergens and with the current absence of immunotherapy 
treatment. A good QoL in rhinoconjunctivitis is found in patients with the fewest 
environmental allergens as well as in adolescents with high levels of environmental 
allergens, food allergy, atopic dermatitis and a low perceived threat of disease.
As previous studies have suggested, adolescents’ perception of the disease may define how 
they adjust to the disease (Valero-Moreno, Lacomba-Trejo et al., 2020). The results found 
using QCA models show that having more allergic diseases or more allergens does not 
necessarily lead adolescents to report greater impairment of their QoL. It is their interpreta-
tion of the disease and the presence of immunotherapy treatment that leads them to report 
fewer associated symptoms. However, although being a boy is generally associated with 
a more limited impact on QoL, the role of sex is not totally clear, and further studies are 
needed. It is important to analyze the role of psychosocial variables in pediatric allergic 
diseases due to the lack of studies on this topic (AUTHOR 1, Castillo-Corullón, et al., 2020).
Despite the contributions made by this study, its limited number of patients and 
monocentric nature may have altered its results, and as such research with a larger, 
nationwide population could obtain different results. Further studies are needed to 
replicate our research, using a probability sample that adequately represents the char-
acteristics and peculiarities of Spanish adolescents with allergies. Future studies should 
have multiple informants and different methods of obtaining the information to assess 
the variables studied, which could reduce the errors commonly made in self-reports, and 
especially those related to social desirability. They could also consider the values obtained 
in spirometry, FeNO and IgE, and consider the nature of the allergens, since our results 
show that the presence of more inhalant allergens is not necessarily associated with 
a poorer QoL in adolescents with ARC and asthma.
The results obtained show that interventions that improve the perception of the disease 
in adolescents could be useful in improving their QoL. Similarly, longer treatment times 
with immunotherapy considerably improve the QoL of adolescents with ARC and asthma. 
These data should be considered when making medical decisions, as immunotherapy has 
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been shown to be medically effective in about 80–90% of cases (Andreasen et al., 2020), but 
our study also sheds light on its impact on the emotional health of adolescents.
In conclusion, it is essential that health professionals specializing in caring for these 
patients have a thorough understanding of the psychological characteristics associated 
with allergic pathology, as this can help reduce the negative impact on their quality of life 
and improve their medical care.
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